Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761871
Exercise and Nutritional Intervention in Patients With Melanoma Receiving ImmunotherapyInstitute of Oncology LjubljanaRecruitingNot Applicable
NCT07761871Recruiting
Not Applicable
Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immuno...Institute of Oncology Lju...
NCT07759947
Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine TherapyMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07759947Not Yet Recruiting
Not Applicable
Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocri...Massachusetts General Hos...
NCT07759882
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)University of ArkansasNot Yet RecruitingNot Applicable
NCT07759882Not Yet Recruiting
Not Applicable
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care Settin...University of Arkansas
NCT07760246
A Study in Healthy People to Measure How Different Doses of Verducatib Affect the HeartBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07760246Not Yet Recruiting
Phase 1
A Study in Healthy People to Measure How Different Doses of Verducatib Affect th...Boehringer Ingelheim
NCT07761351
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted BronchoscopyIntuitive SurgicalNot Yet RecruitingPhase 4
NCT07761351Not Yet Recruiting
Phase 4
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-...Intuitive Surgical
NCT07760610
Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL After First-Line ResponseThe First Hospital of Jilin UniversityNot Yet RecruitingPhase 4
NCT07760610Not Yet Recruiting
Phase 4
Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL...The First Hospital of Jil...
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07759843
Evaluating AI for Diagnosing and Treating Gummy Smiles: A Pilot StudyCairo UniversityRecruiting
NCT07759843Recruiting
—
Evaluating AI for Diagnosing and Treating Gummy Smiles: A Pilot StudyCairo University
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07761442
Comparison Between Socket Shield and Conventional Techniques in Immediate Implant Placement.Minia UniversityRecruitingNot Applicable
NCT07761442Recruiting
Not Applicable
Comparison Between Socket Shield and Conventional Techniques in Immediate Implan...Minia University
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07761533
PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDSChaser Therapeutics, Inc.RecruitingPhase 1
NCT07761533Recruiting
Phase 1
PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDSChaser Therapeutics, Inc.
NCT07759492
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung CancerIntergroupe Francophone de Cancerologie ThoraciqueNot Yet RecruitingPhase 2
NCT07759492Not Yet Recruiting
Phase 2
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cance...Intergroupe Francophone d...
NCT07761325
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic ChemotherapySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 3
NCT07761325Not Yet Recruiting
Phase 3
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone...Sun Yat-Sen Memorial Hosp...
NCT07760324
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Disease Research in ZambiaSuspended
NCT07760324Suspended
—
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Dis...
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07760792
Risk Factors and Clinical Implications of Double-J Ureteral Stent Bacterial ColonizationAl-Azhar UniversityNot Yet Recruiting
NCT07760792Not Yet Recruiting
—
Risk Factors and Clinical Implications of Double-J Ureteral Stent Bacterial Colo...Al-Azhar University
NCT07761338
The Use of Advanced Platelet-rich Fibrin in Mandibular Third Molar SurgeryUniversity of CopenhagenCompleted
NCT07761338Completed
—
The Use of Advanced Platelet-rich Fibrin in Mandibular Third Molar SurgeryUniversity of Copenhagen
NCT07760883
Metformin Effects According to SLC16A11 Carrier StatusInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRecruiting
NCT07760883Recruiting
—
Metformin Effects According to SLC16A11 Carrier StatusInstituto Nacional de Cie...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed2 (10%)
Suspended1 (5%)
not_applicable6 (30%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 23 (15%)
Phase 42 (10%)
Phase 31 (5%)